{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:28:33Z","timestamp":1787941713519,"version":"build-2784847793"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1093\/jac\/dkh449","type":"journal-article","created":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:24:34Z","timestamp":1097195074000},"page":"870-875","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum \u03b2-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria"],"prefix":"10.1093","volume":"54","author":[{"given":"Enno","family":"St\u00fcrenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias A.","family":"Horstkotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11]]},"reference":[{"key":"key\n\t\t\t\t20171010185747_R1","doi-asserted-by":"crossref","unstructured":"St\u00fcrenburg, E. & Mack, D. (2003). Extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory. Journal of Infection47, 273\u201395.","DOI":"10.1016\/S0163-4453(03)00096-3"},{"key":"key\n\t\t\t\t20171010185747_R2","doi-asserted-by":"crossref","unstructured":"Bradford, P. A. (2001). Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews14, 933\u201351.","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"key\n\t\t\t\t20171010185747_R3","doi-asserted-by":"crossref","unstructured":"Albertini, M. T., Benoit, C., Berardi, L. et al. (2002). Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum \u03b2-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. Journal of Hospital Infection52, 107\u201313.","DOI":"10.1053\/jhin.2002.1286"},{"key":"key\n\t\t\t\t20171010185747_R4","doi-asserted-by":"crossref","unstructured":"Spanu, T., Luzzaro, F., Perilli, M. et al. (2002). Occurrence of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to \u03b2-lactams and other antimicrobial drugs. Antimicrobial Agents and Chemotherapy46, 196\u2013202.","DOI":"10.1128\/AAC.46.1.196-202.2002"},{"key":"key\n\t\t\t\t20171010185747_R5","doi-asserted-by":"crossref","unstructured":"Coudron, P. E., Moland, E. S. & Sanders, C. C. (1997). Occurrence and detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. Journal of Clinical Microbiology35, 2593\u20137.","DOI":"10.1128\/JCM.35.10.2593-2597.1997"},{"key":"key\n\t\t\t\t20171010185747_R6","doi-asserted-by":"crossref","unstructured":"Bonnet, R., De Champs, C., Sirot, D. et al. (1999). Diversity of TEM mutants in Proteus mirabilis. Antimicrobial Agents and Chemotherapy43, 2671\u20137.","DOI":"10.1128\/AAC.43.11.2671"},{"key":"key\n\t\t\t\t20171010185747_R7","doi-asserted-by":"crossref","unstructured":"Bonomo, R. A. & Rice, L. B. (1999). Inhibitor resistant class A \u03b2-lactamases. Frontiers in Bioscience4, e34\u2013e41.","DOI":"10.2741\/A477"},{"key":"key\n\t\t\t\t20171010185747_R8","doi-asserted-by":"crossref","unstructured":"Philippon, A., Arlet, G. & Jacoby, G. A. (2002). Plasmid-determined AmpC-type \u03b2-lactamases. Antimicrobial Agents and Chemotherapy46, 1\u201311.","DOI":"10.1128\/AAC.46.1.1-11.2002"},{"key":"key\n\t\t\t\t20171010185747_R9","doi-asserted-by":"crossref","unstructured":"Xiang, X., Shannon, K. & French, G. (1997). Mechanism and stability of hyperproduction of the extended-spectrum \u03b2-lactamase SHV-5 in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy40, 525\u201332.","DOI":"10.1093\/jac\/40.4.525"},{"key":"key\n\t\t\t\t20171010185747_R10","doi-asserted-by":"crossref","unstructured":"Martinez-Martinez, L., Pascual, A., Hernandez-Alles, S. et al. (1999). Roles of \u03b2-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy43, 1669\u201373.","DOI":"10.1128\/AAC.43.7.1669"},{"key":"key\n\t\t\t\t20171010185747_R11","doi-asserted-by":"crossref","unstructured":"Gazouli, M., Tzouvelekis, L. S., Prinarakis, E. E. et al. (1996). Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 \u03b2-lactamase (LAT-2). Antimicrobial Agents and Chemotherapy40, 1736\u201340.","DOI":"10.1128\/AAC.40.7.1736"},{"key":"key\n\t\t\t\t20171010185747_R12","doi-asserted-by":"crossref","unstructured":"Gazouli, M., Tzouvelekis, L. S., Vatopoulos, A. C. et al. (1998). Transferable class C \u03b2-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC \u03b2-lactamase. Journal of Antimicrobial Chemotherapy42, 419\u201325.","DOI":"10.1093\/jac\/42.4.419"},{"key":"key\n\t\t\t\t20171010185747_R13","doi-asserted-by":"crossref","unstructured":"M'Zali, F. H., Heritage, J., Gascoyne-Binzi, D. M. et al. (1997). Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type \u03b2-lactamase exposed during an outbreak of SHV-5 extended-spectrum \u03b2-lactamase in a Leeds hospital. Journal of Antimicrobial Chemotherapy40, 823\u201331.","DOI":"10.1093\/jac\/40.6.823"},{"key":"key\n\t\t\t\t20171010185747_R14","doi-asserted-by":"crossref","unstructured":"St\u00fcrenburg, E., Sobottka, I., Mack, D. et al. (2002). Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin linked to carbapenem resistance. International Journal of Medical Microbiology291, 649\u201354.","DOI":"10.1078\/1438-4221-00175"},{"key":"key\n\t\t\t\t20171010185747_R15","doi-asserted-by":"crossref","unstructured":"Bonnet, R. (2004). Growing group of extended-spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy48, 1\u201314.","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"key\n\t\t\t\t20171010185747_R16","unstructured":"National Committee for Clinical Laboratory Standards. (2003). Performance Standards for Antimicrobial Susceptibility Testing\u2014Thirteenth Informational Supplement M100-S13. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010185747_R17","doi-asserted-by":"crossref","unstructured":"St\u00fcrenburg, E., Sobottka, I., Feucht, H. H. et al. (2003). Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum \u03b2-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagnostic Microbiology and Infectious Disease45, 29\u201334.","DOI":"10.1016\/S0732-8893(02)00481-9"},{"key":"key\n\t\t\t\t20171010185747_R18","doi-asserted-by":"crossref","unstructured":"St\u00fcrenburg, E., Sobottka, I., Noor, D. et al. (2004). Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum \u03b2-lactamases in an Enterobacteriaceae strain collection. Journal of Antimicrobial Chemotherapy54, 134\u20138.","DOI":"10.1093\/jac\/dkh274"},{"key":"key\n\t\t\t\t20171010185747_R19","doi-asserted-by":"crossref","unstructured":"Arlet, G., Rouveau, M. & Philippon, A. (1997). Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum \u03b2-lactamase. FEMS Microbiology Letters152, 163\u20137.","DOI":"10.1016\/S0378-1097(97)00196-1"},{"key":"key\n\t\t\t\t20171010185747_R20","doi-asserted-by":"crossref","unstructured":"Steward, C. D., Rasheed, J. K., Hubert, S. K. et al. (2001). Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum \u03b2-lactamase detection methods. Journal of Clinical Microbiology39, 2864\u201372.","DOI":"10.1128\/JCM.39.8.2864-2872.2001"},{"key":"key\n\t\t\t\t20171010185747_R21","doi-asserted-by":"crossref","unstructured":"Poirel, L., Le Thomas, I., Naas, T. et al. (2000). Biochemical sequence analyses of GES-1, a novel class A extended-spectrum \u03b2-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy44, 622\u201332.","DOI":"10.1128\/AAC.44.3.622-632.2000"},{"key":"key\n\t\t\t\t20171010185747_R22","doi-asserted-by":"crossref","unstructured":"St\u00fcrenburg, E., K\u00fchn, A., Mack, D. et al. (2004). A novel extended-spectrum \u03b2-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. Journal of Antimicrobial Chemotherapy54, 406\u20139.","DOI":"10.1093\/jac\/dkh334"},{"key":"key\n\t\t\t\t20171010185747_R23","doi-asserted-by":"crossref","unstructured":"Livermore, D. M. (1995). \u03b2 -Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews8, 557\u201384.","DOI":"10.1128\/CMR.8.4.557"},{"key":"key\n\t\t\t\t20171010185747_R24","doi-asserted-by":"crossref","unstructured":"Livermore, D. M., Winstanley, T. G. & Shannon, K. P. (2001). Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. Journal of Antimicrobial Chemotherapy48, 87\u2013102.","DOI":"10.1093\/jac\/48.suppl_1.87"},{"key":"key\n\t\t\t\t20171010185747_R25","doi-asserted-by":"crossref","unstructured":"Perez-Perez, F. J. & Hanson, N. D. (2002). Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology40, 2153\u201362.","DOI":"10.1128\/JCM.40.6.2153-2162.2002"},{"key":"key\n\t\t\t\t20171010185747_R26","unstructured":"National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Sixth Edition: Approved Standard M7-A6. Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010185747_R27","doi-asserted-by":"crossref","unstructured":"Hanson, N. D. (2003). AmpC \u03b2-lactamases: what do we need to know for the future? Journal of Antimicrobial Chemotherapy52, 2\u20134.","DOI":"10.1093\/jac\/dkg284"},{"key":"key\n\t\t\t\t20171010185747_R28","doi-asserted-by":"crossref","unstructured":"Thomson, K. S. (2001). Controversies about extended-spectrum and AmpC \u03b2-lactamases. Emerging Infectious Diseases7, 333\u20136.","DOI":"10.3201\/eid0702.010238"},{"key":"key\n\t\t\t\t20171010185747_R29","doi-asserted-by":"crossref","unstructured":"Livermore, D. M. & Brown, D. F. (2001). Detection of \u03b2-lactamase-mediated resistance. Journal of Antimicrobial Chemotherapy48,Suppl 1, 59\u201364.","DOI":"10.1093\/jac\/48.suppl_1.59"},{"key":"key\n\t\t\t\t20171010185747_R30","doi-asserted-by":"crossref","unstructured":"Potz, N. A., Colman, M., Warner, M. et al. (2004). False-positive extended-spectrum \u03b2-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 \u03b2-lactamase. Journal of Antimicrobial Chemotherapy53, 545\u20137.","DOI":"10.1093\/jac\/dkh112"},{"key":"key\n\t\t\t\t20171010185747_R31","doi-asserted-by":"crossref","unstructured":"Urban, C., Go, E., Mariano, N. et al. (1995). Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible Acinetobacter baumannii. FEMS Microbiology Letters125, 193\u20137.","DOI":"10.1111\/j.1574-6968.1995.tb07357.x"},{"key":"key\n\t\t\t\t20171010185747_R32","doi-asserted-by":"crossref","unstructured":"Higgins, P. G., Wisplinghoff, H., Stefanik, D. et al. (2004). In vitro activities of the \u03b2-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with \u03b2-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrobial Agents and Chemotherapy48, 1586\u201392.","DOI":"10.1128\/AAC.48.5.1586-1592.2004"},{"key":"key\n\t\t\t\t20171010185747_R33","doi-asserted-by":"crossref","unstructured":"Pandey, A., Kapil, A., Sood, S. et al. (1998). In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii. Journal of Clinical Microbiology36, 3415\u20136.","DOI":"10.1128\/JCM.36.11.3415-3416.1998"},{"key":"key\n\t\t\t\t20171010185747_R34","doi-asserted-by":"crossref","unstructured":"Walsh, T. R., MacGowan, A. P. & Bennett, P. M. (1997). Sequence analysis and enzyme kinetics of the L2 serine \u03b2-lactamase from Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy41, 1460\u20134.","DOI":"10.1128\/AAC.41.7.1460"},{"key":"key\n\t\t\t\t20171010185747_R35","doi-asserted-by":"crossref","unstructured":"Poirel, L., Karim, A., Mercat, A. et al. (1999). Extended-spectrum \u03b2-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. Journal of Antimicrobial Chemotherapy43, 157\u20138.","DOI":"10.1093\/jac\/43.1.157"},{"key":"key\n\t\t\t\t20171010185747_R36","doi-asserted-by":"crossref","unstructured":"Vahaboglu, H., Ozturk, R., Aygun, H. et al. (1997). Widespread detection of PER-1-type extended-spectrum \u03b2-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrobial Agents and Chemotherapy41, 2265\u20139.","DOI":"10.1128\/AAC.41.10.2265"},{"key":"key\n\t\t\t\t20171010185747_R37","doi-asserted-by":"crossref","unstructured":"Nordmann, P. (1998). Trends in \u03b2-lactam resistance among Enterobacteriaceae. Clinical Infectious Diseases27, S100\u20136.","DOI":"10.1086\/514905"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/5\/870\/2429749\/dkh449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:59:46Z","timestamp":1585904386000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/5\/870\/812058\/Evaluation-of-the-MicroScan-ESBL-plus-confirmation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,11]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh449","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}